Oxidative stress and benefits of antioxidant agents in acute and chronic hepatitis

Hepatitis Monthly

Volumn 12, Issue 3, 2012, Pages 160-167

  Esrefoglu, Mukaddes ^a  

^a BEZMIALEM VAKIF UNIVERSITY   (Turkey)

Author keywords

Antioxidants; Hepatitis; Oxidative stress

Indexed keywords

ACETYLCYSTEINE; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; BILIRUBIN; BIOTIN; CATALASE; COPPER; FOLIC ACID; GALACTOSAMINE; GLUTATHIONE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1; INTERLEUKIN 6; MAGNESIUM; MALONALDEHYDE; MANGANESE; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; SELENIUM; SILYMARIN; SUPEROXIDE DISMUTASE; THIOCTIC ACID; THIOL; TUMOR NECROSIS FACTOR ALPHA; UBIQUINONE; UNINDEXED DRUG; VITAMIN; ZINC;

ACUTE HEPATITIS; CHRONIC HEPATITIS; HEPATITIS B; HEPATITIS C; HUMAN; LIPID PEROXIDATION; LIVER INJURY; NONHUMAN; OXIDATIVE STRESS; REVIEW;

EID: 84861012202     PISSN: 1735143X     EISSN: 17353408     Source Type: Journal    
DOI: 10.5812/hepatmon.5090     Document Type: Review

References (92)

1. Droge W. Free radicals in the physiological control of cell function. Physiol Rev. 2002;82(1):47-95.
2. Hensley K, Robinson KA, Gabbita SP, Salsman S, Floyd RA. Reactive oxygen species, cell signaling, and cell injury. Free Radic Biol Med. 2000;28(10):1456-62.
3. Vrba J, Modriansky M. Oxidative burst of Kupffer cells: target for liver injury treatment. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2002;146(2):15-20.
4. Loguercio C, Federico A. Oxidative stress in viral and alcoholic hepatitis. Free Radic Biol Med. 2003;34(1):1-10.
5. Stehbens WE. Oxidative stress in viral hepatitis and AIDS. Exp Mol Pathol. 2004;77(2):121-32.
6. Jaeschke H. Reactive oxygen and mechanisms of inflammatory liver injury. J Gastroenterol Hepatol. 2000;15(7):718-24.
7. Chrobot AM, Szaflarska-Szczepanik A, Drewa G. Antioxidant defense in children with chronic viral hepatitis B and C. Med Sci Monit. 2000;6(4):713-8.
8. Acar A, Gorenek L, Aydin A, Eyigun CP, Eken A, Sayal A, et al. [Investigation of oxidative stress and antioxidant defense in patients with hepatitis B virus infection and the effect of interferon-alpha plus lamivudine combination therapy on oxidative stress]. Mikrobiyol Bul. 2009;43(3):411-23.
9. Shigesawa T, Sato C, Marumo F. Significance of plasma glutathione determination in patients with alcoholic and non-alcoholic liver disease. J Gastroenterol Hepatol. 1992;7(1):7-11.
10. Choi J, Ou JH. Mechanisms of liver injury. III. Oxidative stress in the pathogenesis of hepatitis C virus. Am J Physiol Gastrointest Liver Physiol. 2006;290(5):G847-51.
11. Lieber CS. Pathogenesis and early diagnosis of alcoholic liver injury. N Engl J Med. 1978;298(16):888-93.
12. Pessayre D, Mansouri A, Fromenty B. Nonalcoholic steatosis and steatohepatitis. V. Mitochondrial dysfunction in steatohepatitis. Am J Physiol Gastrointest Liver Physiol. 2002;282(2):G193-9.
13. Kukielka E, Dicker E, Cederbaum AI. Increased production of reactive oxygen species by rat liver mitochondria after chronic ethanol treatment. Arch Biochem Biophys. 1994;309(2):377-86.
14. Grossi S, Sumberaz A, Gosmar M, Mattioli F, Testino G, Martelli A. DNA damage in peripheral blood lymphocytes of patients with cirrhosis related to alcohol abuse or to hepatitis B and C viruses. Eur J Gastroenterol Hepatol. 2008;20(1):22-5.
15. Vargiu C, Belliardo S, Cravanzola C, Grillo MA, Colombatto S. Oxygen regulation of rat hepatocyte iNOS gene expression. J Hepatol. 2000;32(4):567-73.
16. Majano PL, Garcia-Monzon C, Lopez-Cabrera M, Lara-Pezzi E, Fernandez-Ruiz E, Garcia-Iglesias C, et al. Inducible nitric oxide synthase expression in chronic viral hepatitis. Evidence for a virus-induced gene upregulation. J Clin Invest. 1998;101(7):1343-52.
17. Sanz-Cameno P, Medina J, Garcia-Buey L, Garcia-Sanchez A, Borque MJ, Martin-Vilchez S, et al. Enhanced intrahepatic inducible nitric oxide synthase expression and nitrotyrosine accumulation in primary biliary cirrhosis and autoimmune hepatitis. J Hepatol. 2002;37(6):723-9.
18. Jaeschke H, Ho YS, Fisher MA, Lawson JA, Farhood A. Glutathione peroxidase-deficient mice are more susceptible to neutrophilmediated hepatic parenchymal cell injury during endotoxemia: importance of an intracellular oxidant stress. Hepatology. 1999;29(2):443-50.
19. Bilzer M, Jaeschke H, Vollmar AM, Paumgartner G, Gerbes AL. Prevention of Kupffer cell-induced oxidant injury in rat liver by atrial natriuretic peptide. Am J Physiol. 1999;276(5 Pt 1):G1137-44.
20. Klaasen CD. Casarett and Doull's Toxicology. In: McGraw-Hill, editor. 5th ed. New York; 1996.
21. Knolle P, Lohr H, Treichel U, Dienes HP, Lohse A, Schlaack J, et al. Parenchymal and nonparenchymal liver cells and their interaction in the local immune response. Z Gastroenterol. 1995;33(10):613-20.
22. Ramadori G, Armbrust T. Cytokines in the liver. Eur J Gastroenterol Hepatol. 2001;13(7):777-84.
23. Adamson GM, Billings RE. Tumor necrosis factor induced oxidative stress in isolated mouse hepatocytes. Arch Biochem Biophys. 1992;294(1):223-9.
24. Caldwell SH, Swerdlow RH, Khan EM, Iezzoni JC, Hespenheide EE, Parks JK, et al. Mitochondrial abnormalities in non-alcoholic steatohepatitis. J Hepatol. 1999;31(3):430-4.
25. Barbaro G, Di Lorenzo G, Asti A, Ribersani M, Belloni G, Grisorio B, et al. Hepatocellular mitochondrial alterations in patients with chronic hepatitis C: ultrastructural and biochemical findings. Am J Gastroenterol. 1999;94(8):2198-205.
26. Jaeschke H, Kleinwaechter C, Wendel A. NADH-dependent reductive stress and ferritin-bound iron in allyl alcohol-induced lipid peroxidation in vivo: the protective effect of vitamin E. Chem Biol Interact. 1992;81(1-2):57-68.
27. Tanikawa K, Torimura T. Studies on oxidative stress in liver diseases: important future trends in liver research. Med Mol Morphol. 2006;39(1):22-7.
28. Curzio M, Esterbauer H, Di Mauro C, Cecchini G, Dianzani MU. Chemotactic activity of the lipid peroxidation product 4-hydroxynonenal and homologous hydroxyalkenals. Biol Chem Hoppe Seyler. 1986;367(4):321-9.
29. Bauer C, Siaplaouras S, Soule HR, Moyle M, Marzi I. A natural glycoprotein inhibitor (NIF) of CD11b/CD18 reduces leukocyte adhesion in the liver after hemorrhagic shock. Shock. 1995;4(3):187-92.
30. Jaeschke H. Enhanced sinusoidal glutathione efflux during endotoxin- induced oxidant stress in vivo. Am J Physiol. 1992;263(1 Pt 1):G60-8.
31. Loguercio C, Di Pierro M. The role of glutathione in the gastrointestinal tract: a review. Ital J Gastroenterol Hepatol. 1999;31(5):401-7.
32. Wang Y, Fisher MA, Jaeschke H. Detoxification of Kupffer cell-derived reactive oxygen and reactive nitrogen species by plasma glutathione during hepatic ischemia-reperfusion. In: Wisse E KD, Balabaud C, editor. Cells of the Hepatic Sinusoid. Leiden: Kupffer Cell Foundation; 1997. p. 205-6.
33. Loguercio C, Piscopo P, Guerriero C, De Girolamo V, Disalvo D, Del Vecchio Blanco C. Effect of alcohol abuse and glutathione administration on the circulating levels of glutathione and on antipyrine metabolism in patients with alcoholic liver cirrhosis. Scand J Clin Lab Invest. 1996;56(5):441-7.
34. Barbaro G, Di Lorenzo G, Ribersani M, Soldini M, Giancaspro G, Bellomo G, et al. Serum ferritin and hepatic glutathione concentrations in chronic hepatitis C patients related to the hepatitis C virus genotype. J Hepatol. 1999;30(5):774-82.
35. Herrera B, Alvarez AM, Sanchez A, Fernandez M, Roncero C, Benito M, et al. Reactive oxygen species (ROS) mediates the mitochondrial-dependent apoptosis induced by transforming growth factor (beta) in fetal hepatocytes. FASEB J. 2001;15(3):741-51.
36. Herrera B, Fernandez M, Alvarez AM, Roncero C, Benito M, Gil J, et al. Activation of caspases occurs downstream from radical oxygen species production, Bcl-xL down-regulation, and early cytochrome C release in apoptosis induced by transforming growth factor beta in rat fetal hepatocytes. Hepatology. 2001;34(3):548-56.
37. Nieminen AL, Saylor AK, Tesfai SA, Herman B, Lemasters JJ. Contribution of the mitochondrial permeability transition to lethal injury after exposure of hepatocytes to t-butylhydroperoxide. Biochem J. 1995;307(Pt 1):99-106.
38. Nieminen AL, Byrne AM, Herman B, Lemasters JJ. Mitochondrial permeability transition in hepatocytes induced by t-BuOOH: NAD(P)H and reactive oxygen species. Am J Physiol. 1997;272(4 Pt 1):C1286-94.
39. Byrne AM, Lemasters JJ, Nieminen AL. Contribution of increased mitochondrial free Ca2+ to the mitochondrial permeability transition induced by tert-butylhydroperoxide in rat hepatocytes. Hepatology. 1999;29(5):1523-31.
40. Aguilar HI, Botla R, Arora AS, Bronk SF, Gores GJ. Induction of the mitochondrial permeability transition by protease activity in rats: a mechanism of hepatocyte necrosis. Gastroenterology. 1996;110(2):558-66.
41. Miyoshi H, Umeshita K, Sakon M, Imajoh-Ohmi S, Fujitani K, Gotoh M, et al. Calpain activation in plasma membrane bleb formation during tert-butyl hydroperoxide-induced rat hepatocyte injury. Gastroenterology. 1996;110(6):1897-904.
42. Muschen M, Warskulat U, Peters-Regehr T, Bode JG, Kubitz R, Haussinger D. Involvement of CD95 (Apo-1/Fas) ligand expressed by rat Kupffer cells in hepatic immunoregulation. Gastroenterology. 1999;116(3):666-77.
43. Myhrstad MC, Carlsen H, Nordstrom O, Blomhoff R, Moskaug JO. Flavonoids increase the intracellular glutathione level by transactivation of the gamma-glutamylcysteine synthetase catalytical subunit promoter. Free Radic Biol Med. 2002;32(5):386-93.
44. Chiu H, Brittingham JA, Laskin DL. Differential induction of heme oxygenase-1 in macrophages and hepatocytes during acetaminophen- induced hepatotoxicity in the rat: effects of hemin and biliverdin. Toxicol Appl Pharmacol. 2002;181(2):106-15.
45. Lin CC, Yin MC. Vitamins B depletion, lower iron status and decreased antioxidative defense in patients with chronic hepatitis C treated by pegylated interferon alfa and ribavirin. Clin Nutr. 2009;28(1):34-8.
46. Souza dos Santos RM, de Bem AF, Colpo E, Bertoncello I, Nogueira CW, Rocha JB. Plasmatic vitamin C in nontreated hepatitis C patients is negatively associated with aspartate aminotransferase. Liver Int. 2008;28(1):54-60.
47. Petta S, Camma C, Scazzone C, Tripodo C, Di Marco V, Bono A, et al. Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C. Hepatology. 2010;51(4):1158-67.
48. Bjelakovic G, Gluud LL, Nikolova D, Bjelakovic M, Nagorni A, Gluud C. Meta-analysis: antioxidant supplements for liver diseases - the Cochrane Hepato-Biliary Group. Aliment Pharmacol Ther. 2010;32(3):356-67.
49. Fiorino S, Conti F, Gramenzi A, Loggi E, Cursaro C, Di Donato R, et al. Vitamins in the treatment of chronic viral hepatitis. Br J Nutr. 2011;105(7):982-9.
50. Nakamura M, Saito H, Ikeda M, Hokari R, Kato N, Hibi T, et al. An antioxidant resveratrol significantly enhanced replication of hepatitis C virus. World J Gastroenterol. 2010;16(2):184-92.
51. Yano M, Ikeda M, Abe K, Dansako H, Ohkoshi S, Aoyagi Y, et al. Comprehensive analysis of the effects of ordinary nutrients on hepatitis C virus RNA replication in cell culture. Antimicrob Agents Chemother. 2007;51(6):2016-27.
52. Stehbens WE. Oxidative stress, toxic hepatitis, and antioxidants with particular emphasis on zinc. Exp Mol Pathol. 2003;75(3):265-76.
53. Villalba JM, Navarro F, Gomez-Diaz C, Arroyo A, Bello RI, Navas P. Role of cytochrome b5 reductase on the antioxidant function of coenzyme Q in the plasma membrane. Mol Aspects Med. 1997;18 (Suppl):S7-13.
54. Tappel AL. Lipid peroxidation damage to cell components. Fed Proc. 1973;32(8):1870-4.
55. Ellis RP, Vorhies MW. Effect of supplemental dietary vitamin E on the serologic response of swine to an Escherichia coli bacterin. J Am Vet Med Assoc. 1976;168(3):231-2.
56. Tengerdy RP, Mathias MM, Nockels CF. Vitamin E, immunity and disease resistance. Adv Exp Med Biol. 1981;135:27-42.
57. Halliwell B. Antioxidants and human disease: a general introduction. Nutr Rev. 1997;55(1 Pt 2):S44-9; discussion S9-52.
58. Catal T, Bolkent S. Combination of selenium and three naturally occurring antioxidants administration protects D-galactosamine- induced liver injury in rats. Biol Trace Elem Res. 2008;122(2):127-36.
59. Sugrobova NP, Medvednik RS, Efimova LV, Katarzhnova TV, Liubarev AE, Shaposhnikov VM, et al. [The effect of ubiquinone-10 on the development of D-galactosamine-induced hepatitis in rats]. Biull Eksp Biol Med. 1992;114(11):504-6.
60. Kono H, Arteel GE, Rusyn I, Sies H, Thurman RG. Ebselen prevents early alcohol-induced liver injury in rats. Free Radic Biol Med. 2001;30(4):403-11.
61. Jia JD, Bauer M, Cho JJ, Ruehl M, Milani S, Boigk G, et al. Antifibrotic effect of silymarin in rat secondary biliary fibrosis is mediated by downregulation of procollagen alpha1(I) and TIMP-1. J Hepatol. 2001;35(3):392-8.
62. Ostrakhovitch EA, Afanas'ev IB. Oxidative stress in rheumatoid arthritis leukocytes: suppression by rutin and other antioxidants and chelators. Biochem Pharmacol. 2001;62(6):743-6.
63. von Herbay A, Stahl W, Niederau C, Sies H. Vitamin E improves the aminotransferase status of patients suffering from viral hepatitis C: a randomized, double-blind, placebo-controlled study. Free Radic Res. 1997;27(6):599-605.
64. Pares A, Planas R, Torres M, Caballeria J, Viver JM, Acero D, et al. Effects of silymarin in alcoholic patients with cirrhosis of the liver: results of a controlled, double-blind, randomized and multicenter trial. J Hepatol. 1998;28(4):615-21.
65. Mato JM, Camara J, Fernandez de Paz J, Caballeria L, Coll S, Caballero A, et al. S-adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial. J Hepatol. 1999;30(6):1081-9.
66. Stewart S, Prince M, Bassendine M, Hudson M, James O, Jones D, et al. A randomized trial of antioxidant therapy alone or with corticosteroids in acute alcoholic hepatitis. J Hepatol. 2007;47(2):277-83.
67. DiCecco SR, Francisco-Ziller N. Nutrition in alcoholic liver disease. Nutr Clin Pract. 2006;21(3):245-54.
68. Phillips M, Curtis H, Portmann B, Donaldson N, Bomford A, O'Grady J. Antioxidants versus corticosteroids in the treatment of severe alcoholic hepatitis--a randomised clinical trial. J Hepatol. 2006;44(4):784-90.
69. Mezey E, Potter JJ, Rennie-Tankersley L, Caballeria J, Pares A. A randomized placebo controlled trial of vitamin E for alcoholic hepatitis. J Hepatol. 2004;40(1):40-6.
70. Cox CA, Hespenheide EE, Caldwell SH. A single center's experience with acute alcoholic steatohepatitis: Corticosteroids compared to combination ursodeoxycholic acid, vitamin C and vitamin E. Gastroenterology. 2001;120(A545).
71. Keays R, Harrison PM, Wendon JA, Forbes A, Gove C, Alexander GJ, et al. Intravenous acetylcysteine in paracetamol induced fulminant hepatic failure: a prospective controlled trial. BMJ. 1991;303(6809):1026-9.
72. Le Moine O, Evrard S, Eisendrath P, Deschamps C, Deviere J. Treatment of alcoholic hepatitis with intravenous n-acetylcysteine (NAC): a pilot trial. Gastroenterology. 2001;118:975.
73. Zhou Z, Liu J, Song Z, McClain CJ, Kang YJ. Zinc supplementation inhibits hepatic apoptosis in mice subjected to a long-term ethanol exposure. Exp Biol Med (Maywood). 2008;233(5):540-8.
74. Das SK, Gupta G, Rao DN, Vasudevan DM. Effect of lecithin with vitamin-B complex and tocopheryl acetate on long-term effect of ethanol induced immunomodulatory activities. Indian J Exp Biol. 2007;45(8):683-8.
75. Par A, Roth E, Miseta A, Hegedus G, Par G, Hunyady B, et al. [Effects of supplementation with the antioxidant flavonoid, silymarin, in chronic hepatitis C patients treated with peg-interferon + ribavirin. A placebo-controlled double blind study]. Orv Hetil. 2009;150(2):73-9.
76. Moscarella S, Giusti A, Marra F, Marena C, Lampertico M, Relli P, et al. Therapeutic and antilipoperoxidant effects of silybin-phosphatidylcholine complex in chronic liver disease: preliminary results. Curr Ther Res Clin Exp. 1993;53:98-110.
77. Buzzelli G, Moscarella S, Giusti A, Duchini A, Marena C, Lampertico M. A pilot study on the liver protective effect of silybin-phosphatidylcholine complex (IdB1016) in chronic active hepatitis. Int J Clin Pharmacol Ther Toxicol. 1993;31(9):456-60.
78. Feher J, Deak G, Muzes G, Lang I, Niederland V, Nekam K, et al. [Liver-protective action of silymarin therapy in chronic alcoholic liver diseases]. Orv Hetil. 1989;130(51):2723-7.
79. Ferenci P, Dragosics B, Dittrich H, Frank H, Benda L, Lochs H, et al. Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver. J Hepatol. 1989;9(1):105-13.
80. Polyak SJ, Morishima C, Lohmann V, Pal S, Lee DY, Liu Y, et al. Identification of hepatoprotective flavonolignans from silymarin. Proc Natl Acad Sci U S A. 2010;107(13):5995-9.
81. Boigk G, Stroedter L, Herbst H, Waldschmidt J, Riecken EO, Schuppan D. Silymarin retards collagen accumulation in early and advanced biliary fibrosis secondary to complete bile duct obliteration in rats. Hepatology. 1997;26(3):643-9.
82. Dehmlow C, Erhard J, de Groot H. Inhibition of Kupffer cell functions as an explanation for the hepatoprotective properties of silibinin. Hepatology. 1996;23(4):749-54.
83. Melhem A, Stern M, Shibolet O, Israeli E, Ackerman Z, Pappo O, et al. Treatment of chronic hepatitis C virus infection via antioxidants: results of a phase I clinical trial. J Clin Gastroenterol. 2005;39(8):737-42.
84. Dong Z. Molecular mechanism of the chemopreventive effect of resveratrol. Mutat Res. 2003;523:145-50.
85. Baur JA, Sinclair DA. Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov. 2006;5(6):493-506.
86. Sener G, Toklu HZ, Sehirli AO, Velioglu-Ogunc A, Cetinel S, Gedik N. Protective effects of resveratrol against acetaminophen-induced toxicity in mice. Hepatol Res. 2006;35(1):62-8.
87. Kasdallah-Grissa A, Mornagui B, Aouani E, Hammami M, Gharbi N, Kamoun A, et al. Protective effect of resveratrol on ethanol-induced lipid peroxidation in rats. Alcohol Alcohol. 2006;41(3):236-9.
88. Gonzalez O, Fontanes V, Raychaudhuri S, Loo R, Loo J, Arumugaswami V, et al. The heat shock protein inhibitor Quercetin attenuates hepatitis C virus production. Hepatology. 2009;50(6):1756-64.
89. Teselkin YO, Babenkova IV, Kolhir VK, Baginskaya AI, Tjukavkina NA, Kolesnik YA, et al. Dihydroquercetin as a means of antioxidative defence in rats with tetrachloromethane hepatitis. Phytother Res. 2000;14(3):160-2.
90. Amalia PM, Possa MN, Augusto MC, Francisca LS. Quercetin prevents oxidative stress in cirrhotic rats. Dig Dis Sci. 2007;52(10):2616-21.
91. Gane EJ, Weilert F, Orr DW, Keogh GF, Gibson M, Lockhart MM, et al. The mitochondria-targeted anti-oxidant mitoquinone decreases liver damage in a phase II study of hepatitis C patients. Liver Int. 2010;30(7):1019-26.
92. Murphy MP, Smith RA. Targeting antioxidants to mitochondria by conjugation to lipophilic cations. Annu Rev Pharmacol Toxicol. 2007;47:629-56.